Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Angina Pectoris D000787 27 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Abdelbary G and Fahmy RH Diazepam-loaded solid lipid nanoparticles: design and characterization. 2009 AAPS PharmSciTech pmid:19277870
Bhalekar MR et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. 2009 AAPS PharmSciTech pmid:19294517
Rao M et al. Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices. 2009 AAPS PharmSciTech pmid:19333763
Scalia S and Mezzena M Incorporation in lipid microparticles of the UVA filter, butyl methoxydibenzoylmethane combined with the UVB filter, octocrylene: effect on photostability. 2009 AAPS PharmSciTech pmid:19381836
Barakat NS et al. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. 2009 Drug Deliv pmid:19555310
Chi N et al. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer. Pharm Dev Technol pmid:19671037
Hamza Yel-S and Aburahma MH Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. 2010 Drug Dev Ind Pharm pmid:19722915
Lin YC et al. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. 2009 PLoS ONE pmid:19838303
Gohel M and Nagori SA Fabrication and evaluation of captopril modified-release oral formulation. 2009 Pharm Dev Technol pmid:19883258
Gökçe EH et al. The effect of geometric shape on the release properties of metronidazole from lipid matrix tablets. 2009 J Biomed Nanotechnol pmid:20055089
Jeong SH and Park K Simple preparation of coated resin complexes and their incorporation into fast-disintegrating tablets. 2010 Arch. Pharm. Res. pmid:20191352
Stanisz B et al. Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase. 2010 Jan-Feb Acta Pol Pharm pmid:20210086
Patel NV et al. Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine. 2010 Acta Pharm pmid:20228040
Rahman Z et al. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. 2010 Eur J Pharm Biopharm pmid:20470882
Mukherjee S et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. 2009 Indian J Pharm Sci pmid:20502539
González-Mira E et al. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. 2011 J Pharm Sci pmid:20575052
Yang R et al. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. 2011 Drug Dev Ind Pharm pmid:20578879
Fini A et al. Theophylline-loaded compritol microspheres prepared by ultrasound-assisted atomization. 2011 J Pharm Sci pmid:20815082
Urbán-Morlán Z et al. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. 2010 Int J Nanomedicine pmid:20856836
Aji Alex MR et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. 2011 Eur J Pharm Sci pmid:20971188
Ghimire M et al. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy. 2011 Eur J Pharm Biopharm pmid:20971189
Durand L et al. Encapsulation of ethylhexyl methoxycinnamate, a light-sensitive UV filter, in lipid nanoparticles. 2010 J Microencapsul pmid:21034364
Shah M et al. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. 2011 Drug Dev Ind Pharm pmid:21128704
Setthacheewakul S et al. Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS). 2011 AAPS PharmSciTech pmid:21181511
Rajkumar M and Bhise S Carbamazepine-loaded porous microspheres for short-term sustained drug delivery. 2010 J Young Pharm pmid:21331184
Scalia S et al. Encapsulation of the UV filters ethylhexyl methoxycinnamate and butyl methoxydibenzoylmethane in lipid microparticles: effect on in vivo human skin permeation. 2011 Skin Pharmacol Physiol pmid:21336009
Fini A et al. Diclofenac salts, part 6: release from lipid microspheres. 2011 J Pharm Sci pmid:21523784
Patel JK et al. In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design. 2009 Res Pharm Sci pmid:21589801
Dhawan S et al. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. 2011 J. Pharm. Pharmacol. pmid:21749381
Gao Y et al. Lipid-polymer composite microspheres for colon-specific drug delivery prepared using an ultrasonic spray freeze-drying technique. 2011 J Microencapsul pmid:21767115
Blasi P et al. Lipid nanoparticles for brain targeting I. Formulation optimization. 2011 Int J Pharm pmid:21827844
Jagdale S et al. Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion. 2011 J Young Pharm pmid:21897658
Kasongo KW et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. 2011 J Pharm Sci pmid:22020815
Pivette P et al. Controlled release of a highly hydrophilic API from lipid microspheres obtained by prilling: analysis of drug and water diffusion processes with X-ray-based methods. 2012 J Control Release pmid:22138071
Roberts M et al. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets. 2012 Drug Dev Ind Pharm pmid:22149472
Scalia S et al. Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy. 2012 J Microencapsul pmid:22208706
Wang G et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. 2012 Int J Nanomedicine pmid:22275840
Spada G et al. Solid lipid nanoparticles with and without hydroxypropyl-β-cyclodextrin: a comparative study of nanoparticles designed for colonic drug delivery. 2012 Nanotechnology pmid:22323085
Stanisz B et al. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. 2013 Drug Dev Ind Pharm pmid:22348774
UÄŸurlu T et al. Effects of lubricants on binary direct compression mixtures. 2010 Drug Discov Ther pmid:22491169
Taveira SF et al. Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin. 2012 J Biomed Nanotechnol pmid:22515073
Estella-Hermoso de Mendoza A et al. Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles. 2012 Nanomedicine (Lond) pmid:22630151
Zhang H et al. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. 2012 Int J Nanomedicine pmid:22787390
Alex A et al. Enhanced delivery of lopinavir to the CNS using Compritol-based solid lipid nanoparticles. 2011 Ther Deliv pmid:22833923
Chen YC et al. Development of terbinafine solid lipid nanoparticles as a topical delivery system. 2012 Int J Nanomedicine pmid:22923986
Han F et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. 2012 Int J Pharm pmid:22989987
Scalia S et al. Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles. 2013 Pharm Dev Technol pmid:22998063
Wolska E and Sznitowska M Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM). 2013 Int J Pharm pmid:23164704
Bose S and Michniak-Kohn B Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. 2013 Eur J Pharm Sci pmid:23246734
Bose S et al. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. 2013 Int J Pharm pmid:23262430